Header Logo

Connection

Xinli Liu to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications Xinli Liu has written about Antineoplastic Agents, Immunological.
Xinli Liu
Connection Strength
0.735
Antineoplastic Agents, Immunological
  1. FceRI?-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma. Blood Adv. 2021 Aug 10; 5(15):3021-3031.
    View in: PubMed
    Score: 0.735
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.